fbpx
  • Home
  • Study Details
Open

Belimumab and Rituximab Compared to Rituximab Alone for the Treatment of Primary Membranous Nephropathy

This is a three-year research study for people with primary membranous nephropathy (primary MN). The study will test if combining belimumab and rituximab is effective in treating Primary MN.

Age & Gender

  • 18 years ~ 75 years
  • Male, Female, Gender Inclusive

Visit Availability

  • Extended hours (M-F, early morning or evening)

Location

North Carolina (Statewide)

What will be asked of you

At each visit, you will meet with a member of the study team and answer questions about your health and your medications. We will take your vitals. Some visits will include the rituximab infusion, the belimumab or placebo being injected under your skin, a 24 hour urine collection, some questionnaires..

Incentives

$50 per visit

In-person visits:
27
Total length of participation:
3 years

Looking for Specific Volunteers

Able to participate:

  • you are not on dialysis and your doctor has not mentioned you will soon need to start dialysis.
  • you have not had a kidney transplant
  • you still have protein spilling in your urine
  • if you know your kidney function level numbers: your eGFR must be >30

Not eligible if:

  • you have been treated with Rituximab in the last 12 months
  • you have been treated with a medication decreasing your immune system in the last 30 days

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

Burnett-Womack Building, 160 Dental Cir, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Vimal Derebail
Medicine-Nephrology

Study Type

Clinical or Medical
Interventional

Study Topics

Kidneys and Liver

IRB Number

19-2028

ClinicalTrials.gov

NCT03949855

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research